Research

Narratives on ISN-ACT Clinical Trials Toolkit

To illustrate the ISN-ACT Clinical Trials Toolkit’s usability and facilitate understanding of important clinical trial methodologies, ISN-ACT Clinical Trials Toolkit subgroup members are developing a series of stories based on various toolkit topics. The first of these narratives, by Augusto Cesar Soares dos Santos and Brendan Smyth, outlines trial randomization methods through a fictional clinical...

Announcing the Winners of Early-Career Researcher Awards

The ISN-KI Early-career Researcher Award recognizes outstanding research in basic and clinical science published in Kidney International (KI) in 2019 and 2020. The winners are: Basic science Sho Hasegawa (Japan) Comprehensive three-dimensional analysis (CUBIC-kidney) visualizes abnormal renal sympathetic nerves after ischemia/reperfusion injury Qi Cao (Australia) Regulatory innate lymphoid cells suppress innate immunity and reduce renal ischemia/reperfusion injury Clinical science Madhav C. Menon (USA) Genome-wide...

Improving Care for Non-Dialysis CKD Patients: KDIGO Guideline published in Kidney International

Kidney International has published the KDIGO Clinical Practice Guideline for management of blood pressure (BP) in chronic kidney disease (CKD), which replaces the 2004 Kidney Disease Quality Outcomes Initiative document on the same topic. This new guideline is designed to help physicians in their clinical decision-making for patients with CKD who are not receiving dialysis. The...

Review of Current and Future Applications in Artificial Intelligence-assisted Renal Pathology

Agnes Fogo, ISN President-elect, is a co-author on AI Applications in Renal Pathology published in Kidney International. The paper presents an integrated review on current and future applications in AI-assisted renal pathology, including data collection and analysis in full-stack AI-assisted renal pathology studies and renal pathology-optimized AI techniques. Since synergetic developments of renal pathology and AI...

Expand Trial Participation Within the Nephrology Community: Join Colleagues Online Tomorrow for #NephTrials

The #NephTrials initiative is an exciting new series of conversations combining: The ISN-ACT Global Trials Focus, identifying and summarizing recent interesting trials relevant to kidney disease. The ISN-ACT Toolkit, guiding anyone wishing to start a clinical trial. Social media expertise from the #NephJC community through blog posts, visual abstracts, and a discussion on each topic held on...

One Week Left to Reward Excellence in Research: Nominate an Early-Career Researcher

The ISN-KI Early-career Researcher Award recognizes outstanding research in basic and clinical science published in Kidney International (KI) in 2019 and 2020. Papers will be assessed on the novelty of research, robustness, and methodologies. Nominate your candidate here before February 23. Only ISN members are eligible to nominate candidates who are: Primary authors ISN members Early-career researchers (less than...

ISN-NEPHJC Collaboration: The #NephTrials Initiative – Join the Conversation on February 16 @ 9 p.m. ET

Help expand trial participation within the nephrology community: Join colleagues online for a lively exchange of ideas on February 16 at 9 p.m. ET. #NephTrials The ISN-ACT (Advancing Clinical Trials) and NephJC are partnering on the #NephTrials initiative to increase awareness of ongoing trials in nephrology and improve understanding of what it takes to design and conduct clinical trials. The #NephTrials initiative is an exciting new series...

ISN Global Trials Focus

Every month the ISN-ACT Team lists interesting new randomized controlled trials (RCTs) from around the world. Highlights: Daily, weekly, or monthly cholecalciferol dosing regimens are similarly effective in children with CKD View the latest trials here. A summary of the highlighted trial is now available in French, Mandarin, Russian, and Spanish. Support equal access to nephrology research: Become an ISN...

ISN-NephJC Collaboration: #NephTrial Initiative

The ISN-ACT (Advancing Clinical Trials) and NephJC are partnering to increase awareness of ongoing trials in nephrology and improve understanding of what it takes to design and conduct clinical trials, especially in terms of different trial designs. The ISN-ACT produces the Global Trials Focus, a monthly list that identifies and summarizes recent interesting trials relevant...

“The International Society of Nephrology Advancing Clinical Trials (ISN-ACT) Network: current activities and future goals” published in KI

The ISN-Advancing Clinical Trials (ISN-ACT) initiative developed the paper, “The International Society of Nephrology Advancing Clinical Trials (ISN-ACT) Network: current activities and future goals,” which is now available in the December edition of Kidney International (KI). The manuscript highlights the need for high-quality clinical trials in the field of nephrology. It outlines the ISN-ACT network’s...